Role of soluble triggering receptor expressed on myeloid cells-1 for diagnosing ventilator-associated pneumonia after cardiac surgery: an observational study

BMC Cardiovascular Disorders

Ana PCP Carlotti¹  Alessandra K Matsuno² 

[1] Department of Pediatrics, Hospital das Clínicas, Ribeirão Preto Medical School, University of São Paulo, Avenida dos Bandeirantes, 3900, 14049-900 Ribeirão Preto, SP, Brazil;Division of Pediatric Critical Care Medicine, Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil

关键词: Postoperative;    Cardiac surgery;    Diagnosis;    Ventilator-associated pneumonia;    Triggering receptor expressed on myeloid cells-1;   

Others  :  855958
DOI  :  10.1186/1471-2261-13-107

 received in 2013-09-05, accepted in 2013-11-27,  发布年份 2013

【 摘 要 】

Background

The diagnosis of ventilator-associated pneumonia (VAP) is a challenge, particularly after cardiac surgery. The use of biological markers of infection has been suggested to improve the accuracy of VAP diagnosis. We aimed to evaluate the usefulness of soluble triggering receptor expressed on myeloid cells (sTREM)-1 in the diagnosis of VAP following cardiac surgery.

Methods

This was a prospective observational cohort study of children with congenital heart disease admitted to the pediatric intensive care unit (PICU) after surgery and who remained intubated and mechanically ventilated for at least 24 hours postoperatively. VAP was defined by the 2007 Centers for Disease Control and Prevention criteria. Blood, modified bronchoalveolar lavage (mBAL) fluid and exhaled ventilator condensate (EVC) were collected daily, starting immediately after surgery until the fifth postoperative day or until extubation for measurement of sTREM-1.

Results

Thirty patients were included, 16 with VAP. Demographic variables, Pediatric Risk of Mortality (PRISM) and Risk Adjustment for Congenital Heart Surgery (RACHS)-1 scores, duration of surgery and length of cardiopulmonary bypass were not significantly diferent in patients with and without VAP. However, time on mechanical ventilation and length of stay in the PICU and in the hospital were significantly longer in the VAP group. Serum and mBAL fluid sTREM-1 concentrations were similar in both groups. In the VAP group, 12 of 16 patients had sTREM-1 detected in EVC, whereas it was undetectable in all but two patients in the non-VAP group over the study period (p = 0.0013) (sensitivity 0.75, specificity 0.86, positive predictive value 0.86, negative predictive value 0.75, positive likelihood ratio (LR) 5.25, negative LR 0.29).

Conclusion

Measurement of sTREM-1 in EVC may be useful for the diagnosis of VAP after cardiac surgery.

【 授权许可】

   
2013 Matsuno and Carlotti; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Matsuno AK, Carlotti APCP, Mussi-Pinhata MM: Nosocomial infection surveillance in Brazilian pediatric intensive care units. Pediatr Crit Care Med 2007, 8(Suppl. 3):A75-A76.
• [2]Roeleveld PP, Guijt D, Kuijper EJ, Hazekamp MG, de Wilde RB, de Jonge E: Ventilator-associated pneumonia in children after cardiac surgery in The Netherlands. Intensive Care Med 2011, 37:1656-1663.
• [3]Guardia Cami MT, Jordan García I, Urrea Ayala M: Nosocomial infections in pediatric patients following cardiac surgery. An Pediatr (Barc) 2008, 69:34-38.
• [4]Tang CW, Liu PY, Huang YF, Pan JY, Lee SS, Hsieh KS, Liu YC, Ger LP: Ventilator-associated pneumonia after pediatric cardiac surgery in southern Taiwan. J Microbiol Immunol Infect 2009, 42:413-419.
• [5]Brix-Christensen V: The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children. Acta Anaesthesiol Scand 2001, 45:671-679.
• [6]Venkatachalam V, Hendley JO, Willson DF: The diagnostic dilemma of ventilator-associated pneumonia in critically ill children. Pediatr Crit Care Med 2011, 12:286-296.
• [7]Fàbregas N, Ewig S, Torres A, El-Ebiary M, Ramirez J, de La Bellacasa JP, Bauer T, Cabello H: Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999, 54:867-873.
• [8]Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE: Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004, 350:451-458.
• [9]Determann RM, Millo JL, Gibot S, Korevaar JC, Vroom MB, van der Poll T, Garrard CS, Schultz MJ: Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med 2005, 31:1495-1500.
• [10]Horonenko G, Hoyt JC, Robbins RA, Singarajah CU, Umar A, Pattengill J, Hayden JM: Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report. Chest 2007, 132:58-63.
• [11]Bouchon A, Facchetti F, Weigand MA, Colonna M: TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001, 410:1103-1107.
• [12]Barraud D, Gibot S: Triggering receptor expressed on myeloid cell 1. Crit Care Clin 2011, 27:265-279.
• [13]Gibot S: Clinical review: role of triggering receptor expressed on myeloid cells-1 during sepsis. Crit Care 2005, 9:485-489. BioMed Central Full Text
• [14]Gibot S, Cravoisy A, Kolopp-Sarda MN, Béné MC, Faure G, Bollaert PE, Levy B: Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med 2005, 33:792-796.
• [15]Adib-Conquy M, Monchi M, Goulenok C, Laurent I, Thuong M, Cavaillon JM, Adrie C: Increased plasma levels of soluble triggering receptor expressed on myeloid cells 1 and procalcitonin after cardiac surgery and cardiac arrest without infection. Shock 2007, 28:406-410.
• [16]Jenkins KJ: Risk adjustment for congenital heart surgery: The RACHS-1 method. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2004, 7:180-184.
• [17]Pollack MM, Ruttimann UE, Getson PR: Pediatric risk of mortality (PRISM) score. Crit Care Med 1988, 16:1110-1116.
• [18]Schindler MB, Cox PN: A simple method of bronchoalveolar lavage. Anaesth Intensive Care 1994, 22:66-68.
• [19]Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002, 165:867-903.
• [20]Garbino J, Gerbase MW, Wunderli W, Deffernez C, Thomas Y, Rochat T, Ninet B, Schrenzel J, Yerly S, Perrin L, Soccal PM, Nicod L, Kaiser L: Lower respiratory viral illnesses: improved diagnosis by molecular methods and clinical impact. Am J Respir Crit Care Med 2004, 170:1197-1203.
• [21]Anand NJ, Zuick S, Klesney-Tait J, Kollef MH: Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest 2009, 135:641-647.
• [22]Grgurich PE, Hudcova J, Lei Y, Sarwar A, Craven DE: Diagnosis of ventilator-associated pneumonia: controversies and working toward a gold standard. Curr Opin Infect Dis 2013, 26:140-150.